Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Jeffrey M. Leiden

At a glance: Jeffrey M. Leiden is Director at Odyssey Therapeutics (ODTX). Their latest SEC Form 4, filed May 11, 2026, reported a purchase of $100K. On file: 1 purchase line ($100K) and 17 sale lines ($60.9M).

Disclosed holdings: about $5.0M of ODTX stock: 270,198 shares reported on their latest Form 4 (filed May 11, 2026), valued at the Nov 19, 2026 close of $18.43. This counts only ODTX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Odyssey Therapeutics, Inc. (ODTX); Chair at Vertex Pharmaceuticals Inc / Ma (VRTX)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+27.0%
vs. S&P 500+22.2%
Beat the market100%
Paper profit on buys−$8K
Total bought / sold$100K / $60.9M

Jeffrey M. Leiden's InsiderPrint

18 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Jeffrey M. Leiden: 18 trades, 2025 to 20262025: 0 buys, 17 sales2026: 1 buy, 0 sales

Reading this print: Almost only sells, trading about 18 times a year, typically $2.0M a trade; most sales are on a pre-planned 10b5-1 schedule; trades in the same month most years.

  • Bump outward: a purchase (1)
  • Dent inward: a sale (17)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Shyam SankarSee Remarks · PLTR · 99% match
  2. Ahn Luis VonCEO, President · DUOL · 99% match
  3. Roy D. BaynesDirector · NTRA · 94% match
  4. Insight Holdings Group, LLC10% Owner · COUR · 92% match
  5. Elizabeth M. AndersonDirector · INSM · 90% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
May 11SEC ODTXOdyssey Therapeutics, Inc.First buyAbove market priceLikely offeringBought at the IPO Buy 5,000270,198 held (+2%) $20.00 $100K -7.8%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 4,46983,338 held (−5%) $440.40 $2.0M +18.4%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 1,32082,018 held (−2%) $441.26 $582K +18.1%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 2,46979,549 held (−3%) $443.21 $1.1M +17.6%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 4,35275,197 held (−5%) $444.36 $1.9M +17.3%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 7,89967,298 held (−11%) $445.56 $3.5M +17.0%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 1,15266,146 held (−2%) $447.05 $515K +16.6%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 2,32063,826 held (−4%) $448.78 $1.0M +16.2%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 5,88057,946 held (−9%) $449.84 $2.6M +15.9%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 5,80952,137 held (−10%) $451.20 $2.6M +15.5%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 15,68136,456 held (−30%) $452.20 $7.1M +15.3%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 10,36026,096 held (−28%) $453.34 $4.7M +15.0%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 2,07024,026 held (−8%) $455.22 $942K +14.5%
Nov 17SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 18,52825,186 held (−42%) $440.22 $8.2M +18.4%
Nov 17SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 1,16024,026 held (−5%) $441.05 $512K +18.2%
Nov 17SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 32,23445,396 held (−42%) $440.30 $14.2M +18.4%
Nov 17SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 21,33024,066 held (−47%) $441.35 $9.4M +18.1%
Nov 17SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 4024,026 held (−0%) $442.00 $18K +17.9%
  • Buy

    Director Jeffrey M Leiden bought $100K of ODTX at $20.00 — first open-market purchase in our records.

  • Sell

    Chair Jeffrey M Leiden sold $2.0M of VRTX at $440.40 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chair Jeffrey M Leiden sold $582K of VRTX at $441.26 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chair Jeffrey M Leiden sold $1.1M of VRTX at $443.21 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chair Jeffrey M Leiden sold $1.9M of VRTX at $444.36 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chair Jeffrey M Leiden sold $3.5M of VRTX at $445.56 — pre-scheduled 10b5-1 plan sale.

Follow Jeffrey M. Leiden

Get one email when Jeffrey M. Leiden files a new purchase or sale. Free.

At most one email a day about Jeffrey M. Leiden, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.